{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T08:07:57Z","timestamp":1772438877863,"version":"3.50.1"},"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0198327","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T13:49:11Z","timestamp":1527860951000},"page":"e0198327","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study"],"prefix":"10.1371","volume":"13","author":[{"given":"Josep","family":"Franch-Nadal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lloren\u00e7","family":"Caballeria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"Mata-Cases","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didac","family":"Mauricio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Giraldez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Mancera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Goday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0318-8657","authenticated-orcid":true,"given":"Xavier","family":"Mundet-Tudur\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Regidor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the PREDAPS Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"issue":"Suppl 1","key":"ref1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S1665-2681(19)31820-4","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)","volume":"8","author":"S Bellentani","year":"2009","journal-title":"Ann Hepatol"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"E Fabbrini","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"ZM Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrgastro.2013.182","article-title":"The genetics of NAFLD","volume":"10","author":"QM Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/MEG.0b013e32832fcdf0","article-title":"Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain","volume":"22","author":"L Caballeria","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.metabol.2016.01.001","article-title":"Non-alcoholic fatty liver disease and diabetes","volume":"65","author":"JM Hazlehurst","year":"2016","journal-title":"Metabolism"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis","volume":"31","author":"S Ballestri","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"QM Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2337\/dc16-1787","article-title":"Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action","volume":"40","author":"F Bril","year":"2017","journal-title":"Diabetes Care"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","article-title":"Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Y Sumida","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.4254\/wjh.v7.i4.638","article-title":"Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease","volume":"7","author":"M Papagianni","year":"2015","journal-title":"World J Hepatol"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"e94059","DOI":"10.1371\/journal.pone.0094059","article-title":"Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance","volume":"9","author":"S Kahl","year":"2014","journal-title":"PLoS ONE"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"G Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"e0120443","DOI":"10.1371\/journal.pone.0120443","article-title":"External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan","volume":"10","author":"BL Yang","year":"2015","journal-title":"PLoS ONE"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","article-title":"External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study","volume":"11","author":"EM Koehler","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1\u20132","key":"ref16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.clinbiochem.2011.10.014","article-title":"Fatty liver index as an indicator of metabolic syndrome","volume":"45","author":"D Rogulj","year":"2012","journal-title":"Clin Biochem"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.22845","article-title":"Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population","volume":"49","author":"A Gastaldelli","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hep.24356","article-title":"Fatty liver index and mortality: the Cremona study in the 15th year of follow-up","volume":"54","author":"G Calori","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/07315724.2016.1262802","article-title":"The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic Patients","volume":"36","author":"M Leutner","year":"2017","journal-title":"J Am Coll Nutr"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/HJH.0000000000001204","article-title":"Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies","volume":"35","author":"F Bonnet","year":"2017","journal-title":"J Hypertens"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"e32710","DOI":"10.1371\/journal.pone.0032710","article-title":"Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes","volume":"7","author":"L Bozkurt","year":"2012","journal-title":"PLoS ONE"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"G Musso","year":"2011","journal-title":"Ann Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-230X-10-56","article-title":"Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study","volume":"10","author":"B Balkau","year":"2010","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/dme.12104","article-title":"Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population","volume":"30","author":"CH Jung","year":"2013","journal-title":"Diabet Med"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"e0124749","DOI":"10.1371\/journal.pone.0124749","article-title":"Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study","volume":"10","author":"S Jager","year":"2015","journal-title":"PLoS ONE"},{"issue":"31","key":"ref26","doi-asserted-by":"crossref","first-page":"e4447","DOI":"10.1097\/MD.0000000000004447","article-title":"Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study","volume":"95","author":"D Yadav","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1440-1746.2006.04781.x","article-title":"Effects of nonalcoholic fatty liver disease on the development of metabolic disorders","volume":"22","author":"JG Fan","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s00535-009-0091-1","article-title":"Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease","volume":"44","author":"Y Arase","year":"2009","journal-title":"J Gastroenterol"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1440-1746.2009.05998.x","article-title":"Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup","volume":"25","author":"T Yamada","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2337\/dc10-1991","article-title":"Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study","volume":"34","author":"JC Bae","year":"2011","journal-title":"Diabetes Care"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/liv.12200","article-title":"Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up","volume":"33","author":"S Zelber-Sagi","year":"2013","journal-title":"Liver Int"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1038\/ajg.2010.275","article-title":"Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects","volume":"105","author":"JC Bae","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/jdi.12290","article-title":"Evaluation of the fatty liver index as a predictor for the development of diabetes among insurance beneficiaries with prediabetes","volume":"6","author":"T Nishi","year":"2015","journal-title":"J Diabetes Investig"},{"issue":"Supplement 1","key":"ref34","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc16-S005","article-title":"Classification and Diagnosis of Diabetes","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"issue":"2","key":"ref35","first-page":"121","article-title":"Cohort Study in Primary Health Care on the Evolution of Patients with Prediabetes (PREDAPS): basis and methodology","volume":"87","author":"R Serrano","year":"2013","journal-title":"Rev Esp Salud Publica"},{"issue":"Suppl 1","key":"ref36","first-page":"S4","article-title":"Standards of Medical Care in Diabetes-2017: Summary of Revisions","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","article-title":"European Association for the Study of D. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"28","author":"R Kahn","year":"2005","journal-title":"Diabetes Care"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/met.2008.0034","article-title":"The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects","volume":"6","author":"LE Simental-Mendia","year":"2008","journal-title":"Metabolic syndrome and related disorders"},{"issue":"7","key":"ref39","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1210\/jc.2010-0288","article-title":"The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp","volume":"95","author":"F Guerrero-Romero","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"ref40","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2337\/dc10-2234","article-title":"The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds","volume":"34","author":"C Giannini","year":"2011","journal-title":"Diabetes Care"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"e50931","DOI":"10.1371\/journal.pone.0050931","article-title":"The association of the triglyceride-to-HDL cholesterol ratio with insulin resistance in White European and South Asian men and women","volume":"7","author":"SA Mostafa","year":"2012","journal-title":"PLoS ONE"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12933-014-0146-3","article-title":"Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance","volume":"13","author":"T Du","year":"2014","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"e0116110","DOI":"10.1371\/journal.pone.0116110","article-title":"Association between lipid ratios and insulin resistance in a Chinese population","volume":"10","author":"L Zhang","year":"2015","journal-title":"PLoS ONE"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"e0149731","DOI":"10.1371\/journal.pone.0149731","article-title":"Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals","volume":"11","author":"LK Er","year":"2016","journal-title":"PLoS ONE"},{"issue":"9","key":"ref45","doi-asserted-by":"crossref","first-page":"e0163465","DOI":"10.1371\/journal.pone.0163465","article-title":"Predictive Value of Triglyceride Glucose Index for the Risk of Incident Diabetes: A 4-Year Retrospective Longitudinal Study","volume":"11","author":"DY Lee","year":"2016","journal-title":"PLoS ONE"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1464-5491.2005.01582.x","article-title":"Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults","volume":"22","author":"S Jimba","year":"2005","journal-title":"Diabet Med"},{"issue":"8","key":"ref47","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1365-2036.2006.03112.x","article-title":"Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease","volume":"24","author":"VW Wong","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4236\/jdm.2014.44040","article-title":"A Study of Prevalence of Diabetes and Prediabetes in Patients of Non-Alcoholic Fatty Liver Disease and the Impact of Diabetes on Liver Histology in Coastal Eastern India","volume":"4","author":"SP Singh","year":"2014","journal-title":"Journal of Diabetes Mellitus"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jceh.2016.06.043","article-title":"A Study of Prevalence of Diabetes and Prediabetes in Patients with Non Alcoholic Fatty Liver Disease and Impact of Diabetes on Liver Histology","volume":"6","author":"A Bansal","year":"2016","journal-title":"Journal of Clinical and Experimental Hepatology"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2337\/dc11-1849","article-title":"Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD)","volume":"35","author":"C Ortiz-Lopez","year":"2012","journal-title":"Diabetes Care"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2931985","DOI":"10.1155\/2016\/2931985","article-title":"The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes","volume":"2016","author":"G Forlani","year":"2016","journal-title":"J Diabetes Res"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome","volume":"47","author":"A Lonardo","year":"2015","journal-title":"Dig Liver Dis"},{"issue":"6","key":"ref53","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s11892-015-0607-4","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms","volume":"15","author":"C Saponaro","year":"2015","journal-title":"Curr Diab Rep"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"D Prati","year":"2002","journal-title":"Ann Intern Med"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.22429","article-title":"Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes","volume":"48","author":"AL Fracanzani","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"ref56","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1210\/jc.2015-1966","article-title":"High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels","volume":"100","author":"P Portillo-Sanchez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"ref57","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00125-003-1036-5","article-title":"Gamma-glutamyltransferase and diabetes\u2014a 4 year follow-up study","volume":"46","author":"DH Lee","year":"2003","journal-title":"Diabetologia"},{"issue":"6","key":"ref58","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1053\/j.gastro.2008.09.018","article-title":"Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease","volume":"135","author":"W Goessling","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"ref59","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.metabol.2009.08.024","article-title":"Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men","volume":"59","author":"S Ryu","year":"2010","journal-title":"Metabolism"},{"issue":"2","key":"ref60","first-page":"117","article-title":"Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society","volume":"215","author":"M Mata-Cases","year":"2015","journal-title":"Rev Clin Esp"},{"issue":"8","key":"ref61","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1210\/jc.2006-2384","article-title":"Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects","volume":"92","author":"F Sato","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1210\/jc.2008-1689","article-title":"Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance","volume":"94","author":"AP Viljanen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"ref63","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1210\/jc.2013-1519","article-title":"Resolution of fatty liver and risk of incident diabetes","volume":"98","author":"KC Sung","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"ref64","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2337\/dc15-0140","article-title":"Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes","volume":"38","author":"H Yamazaki","year":"2015","journal-title":"Diabetes Care"},{"issue":"12","key":"ref65","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jamainternmed.2014.5294","article-title":"Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study","volume":"174","author":"SA Berkowitz","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"5","key":"ref66","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","author":"S McPherson","year":"2015","journal-title":"J Hepatol"},{"issue":"4","key":"ref67","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ecl.2016.06.005","article-title":"Nonalcoholic Fatty Liver Disease: The New Complication of Type 2 Diabetes Mellitus","volume":"45","author":"F Bril","year":"2016","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"ref68","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1774","article-title":"Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial","volume":"165","author":"K Cusi","year":"2016","journal-title":"Ann Intern Med"},{"issue":"7","key":"ref69","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00125-010-1720-1","article-title":"Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients","volume":"53","author":"G Targher","year":"2010","journal-title":"Diabetologia"},{"issue":"3","key":"ref70","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis","volume":"65","author":"G Targher","year":"2016","journal-title":"J Hepatol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.metabol.2017.02.014","article-title":"The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement","volume":"71","author":"VG Athyros","journal-title":"Metabolism\u2014Clinical and Experimental"},{"issue":"4","key":"ref72","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"M Ekstedt","year":"2006","journal-title":"Hepatology"},{"issue":"4","key":"ref73","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ajg.2011.400","article-title":"Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults","volume":"107","author":"DH Sinn","year":"2012","journal-title":"Am J Gastroenterol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0198327","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T20:33:03Z","timestamp":1571430783000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0198327"}},"subtitle":[],"editor":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":73,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0198327","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}